When was Pfizer founded?

Pfizer was founded in 1849 and raised its 1st funding round 160 years after it was founded.

Where is Pfizer located?

Pfizer is headquartered in New York City, United States. It is registered at Peapack, New Jersey.

Which legal entities is Pfizer associated with?

Pfizer is associated with PFIZER LIMITED and 10 others.

How many employees does Pfizer have?

As of Sep 30, 2026, the latest employee count at Pfizer is 108229.

Is Pfizer a funded company?

Pfizer is a funded company, having raised an undisclosed amount across 11 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Jun 02, 2009.

When was the latest funding round of Pfizer?

Pfizer's latest funding was a $***** Grant (prize money) round on Jun 27, 2023, with participation from 1 investor. Its primary sector is Traditional Pharmaceuticals. Globally, the Traditional Pharmaceuticals sector has seen $1.29B in funding in 2026 to date.

Where does Pfizer rank among its competitors?

Pfizer ranks 10th amongst 1767 active competitors, of which 110 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of Pfizer?

Pfizer's top competitors include AbbVie, Merck and Gilead. Among them, AstraZeneca secured the most recent funding round in July, 2025.

Pfizer - 2026 Company Profile, Team, Funding & Competitors

Pfizer is a public company based in New York City (United States), founded in 1849 by Charles Pfizer, Charles Erhart and Brenda Wen. It operates as a Provider of pharmaceutical products for multiple disease treatments. Pfizer has raised an undisclosed amount in funding. The company has 1767 active competitors, including 110 funded and 226 that have exited. Its top competitors include companies like AbbVie, Merck and Gilead.

Company Details

Provider of pharmaceutical products for multiple disease treatments. It has developed a novel cancer medicine that works by inhibiting blood supply in tumor cells and destroys cellular reproduction. The other product includes Chantix that helps smokers to quit smoking.In 2022, the company recorded annual revenues of $92.95B and a net profit of $29.04B.

Website: www.pfizer.com/
Social
Phone Number: +1 **********
Registered Address: Peapack, New Jersey

Key Metrics

Founded Year

1849

Location

New York City, United States

Stage

Public

Latest Funding Round

Grant (prize money), Jun 27, 2023, $*****

Investors

Berkshire Hathaway & 17 more

Ranked

10^th among 1767 active competitors

Employee Count

108,229 as on Sep 30, 2026

Investment & Acquisitions

Flare Therapeutics & 200 more

Similar Companies

AbbVie & 3550 more

Exit Details

Public

View Pfizer's full profile

Pfizer is associated with 11 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
PFIZER INC CIN: 0713.748.368 , Belgium, Active	Aug 01, 2018	€1B+ (As on Dec 31, 2023)	-	-
PFIZER (THAILAND) COMPANY LIMITED CIN: 0105511004048 , Thailand, Active	Aug 16, 1968	$100M - $500M (As on Dec 31, 2023)	-
PFIZER AS CIN: 915213596 , Norway, Active	Nov 24, 1959	-	108 (As on Dec 31, 2022)
Pfizer Export B.V. CIN: 26397472429 , Croatia, Active	Jun 26, 2017	$1M - $10M (As on Nov 30, 2018)	-
Trillium Therapeutics Inc. CIN: 1616212 , United States, Active	Mar 25, 2015	$0 - $1M (As on Dec 31, 2020)	-	-
PFIZER LIMITED CIN: L24231MH1950PLC008311 , India, Active	Nov 21, 1950	₹1,000+ Cr (As on Mar 31, 2025)	1711 (As on Feb 29, 2024)
WATSON PHARMA PRIVATE LIMITED CIN: U24230MH2005PTC156968 , India, Active	Oct 21, 2005	₹1,000+ Cr (As on Mar 31, 2025)	1035 (As on Mar 31, 2024)
PFIZER PRODUCTS INDIA PRIVATE LIMITED CIN: U24230MH1996FTC148003 , India, Active	Dec 19, 1996	₹500 - ₹1,000 Cr (As on Mar 31, 2025)	399 (As on Aug 01, 2025)
PFIZER HEALTHCARE INDIA PRIVATE LIMITED CIN: U24232TN2009PTC073563 , India, Active	Nov 17, 2009	₹1,000+ Cr (As on Mar 31, 2025)	2457 (As on Feb 29, 2024)
PFIZER PHARMACEUTICALS LLC CIN: 660577291 , United States, Active	Dec 31, 1999	-	1362 (As on Dec 31, 2024)	-
Pfizer Inc CIN: 135315170 , United States, Active	Dec 26, 999	-	29469 (As on Dec 31, 2024)	-

Pfizer got listed on Dec 21, 1984.

Click here to take a look at Pfizer's IPO in detail

Pfizer has raised funding over 11 rounds. Its first funding round was on Jun 02, 2009. Its latest funding round was a Grant (prize money) round on Jun 27, 2023 for $*****. 1 investor participated in its latest round. Pfizer has 18 institutional investors.

Here is the list of recent funding rounds of Pfizer:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 27, 2023	9731146	Grant (prize money)	7633960	5908443	5343207	3533924
Jan 01, 2020	4051670	Grant (prize money)	3875897	7877716	5731895	Europa
Sep 2018	6478012	Conventional Debt	7031861	5762159	1599574	4488489

Access funding benchmarks and valuations. Sign up today!

View details of Pfizer's funding rounds and investors

The founders of Pfizer are Charles Pfizer, Charles Erhart and Brenda Wen. Albert Bourla is the CEO of Pfizer.

Here are the details of Pfizer's key team members:

Charles Pfizer: Former Co-Founder of Pfizer and founder of 1 other company.
Charles Erhart: Former Co-Founder of Pfizer and founder of 1 other company.
Brenda Wen: Co-founder and Board of Directors of Pfizer.
Albert Bourla: CEO of Pfizer.

View details of Pfizer's Founder profiles and Board Members

Pfizer's employee count trend

Pfizer has 108,229 employees as of Sep 26. Here is Pfizer's employee count trend over the years:

Uncover Pfizer's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pfizer include AbbVie, Merck and Gilead. Here is the list of Top 10 competitors of Pfizer, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 10 others	84/100
2nd	Merck 1891, Rahway (United States), Public	Manufacturer of pharmaceutical products	-	Bill & Melinda Gates Foundation, Berkshire Hathaway ... & 11 others	83/100
3rd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Jindal Ventures & 18 others	82/100
4th	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	80/100
5th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	77/100
6th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	76/100
7th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 17 others	76/100
8th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	72/100
9th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 12 others	71/100
10th	Pfizer 1849, New York City (United States), Public	Provider of pharmaceutical products for multiple disease treatments	-	Berkshire Hathaway, Alcor Fund & 16 others	71/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Pfizer's competitors? Click here to see the top ones

Pfizer has made 164 investments in companies including Flare Therapeutics and Oblenio Bio. Pfizer has also acquired 37 companies including Metsera and Seattle Genetics.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jun 30, 2026	Investments	Flare Therapeutics	2021	Cambridge (United States)
Jun 25, 2026	Investments	Oblenio Bio		Cambridge (United States)
May 06, 2026	Investments	CellCentric	2003	Cambridge (United Kingdom)